http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109971759-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2019-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109971759-B |
| titleOfInvention | circ _ ADARB1, application thereof in preparation of nasopharyngeal carcinoma diagnostic preparation and diagnostic preparation |
| abstract | The invention belongs to the technical field of tumor molecular biology, and particularly relates to circ _ ADARB1, and application thereof in preparation of a nasopharyngeal carcinoma diagnostic preparation and the diagnostic preparation. A plurality of nasopharyngeal carcinoma tissues and normal inflammatory nasopharyngeal epithelial tissues are collected, and the expression condition of circ _ ADARB1 is detected by utilizing a qRT-PCR technology. The results showed that circ _ ADARB1 was significantly highly expressed in 22 nasopharyngeal carcinoma tissues compared to 12 normal inflammatory nasopharyngeal epithelium tissues, and the level of circ _ ADARB1 expression in the nasopharyngeal carcinoma group was about 4-fold higher than that in the normal inflammatory nasopharyngeal epithelium, and the difference between the two groups of data was statistically significant (p ═ 0.0044). Therefore, the high expression of circ _ ADARB1 in nasopharyngeal carcinoma tissues suggests that circ _ ADARB1 may be a diagnostic marker for nasopharyngeal carcinoma and a reagent for preparing a diagnostic reagent for nasopharyngeal carcinoma. Has profound clinical significance and important popularization and application prospect. |
| priorityDate | 2019-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.